Journal for ImmunoTherapy of Cancer (Nov 2020)
76 Potential mechanisms of resistance identified through analysis of multiple biomarkers in immune hot non-responders with non-small cell lung cancer (NSCLC) treated with tislelizumab
Abstract
No abstracts available.